Technical Analysis for TH - Theratechnologies Inc.

Grade Last Price % Change Price Change
grade F 2.35 -2.89% -0.070
TH closed down 2.89 percent on Wednesday, June 3, 2020, on 74 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical TH trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -2.89%
Lower Bollinger Band Walk Weakness -2.89%
Inside Day Range Contraction -2.89%
Wide Bands Range Expansion -2.89%
Lower Bollinger Band Touch Weakness -2.89%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Theratechnologies Inc. is a specialty pharmaceutical company. The Company addresses medical needs to promote healthy living among human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy. EGRIFTA is indicated for the treatment of excess visceral adipose tissue (VAT), as assessed by waist circumference of approximately 100 centimeters for males and approximately 90 centimeters for females. Ibalizumab is a cluster difference 4 (CD4)-directed HIV entryinhibitor, which focuses on treating multidrug resistant HIV-1 infection (MDR HIV-1). ibalizumab binds to the second extracellular domain of the CD4 receptor. Ibalizumab has completed the Phase III trial. EGRIFTA is available in Canada and in the United States. The Company distributes EGRIFTA in the United States through RxC Acquisition Company.
Medical Specialties Pharmaceutical Immunology Organ Systems Infection Hiv

Is TH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.98
52 Week Low 1.93
Average Volume 146,745
200-Day Moving Average 3.968
50-Day Moving Average 2.911
20-Day Moving Average 2.895
10-Day Moving Average 2.710
Average True Range 0.243
ADX 15.87
+DI 14.373
-DI 25.782
Chandelier Exit (Long, 3 ATRs ) 2.762
Chandelier Exit (Short, 3 ATRs ) 3.028
Upper Bollinger Band 3.504
Lower Bollinger Band 2.286
Percent B (%b) 0.05
BandWidth 42.059
MACD Line -0.188
MACD Signal Line -0.109
MACD Histogram -0.0789
Fundamentals Value
Market Cap 176.07 Million
Num Shares 74.9 Million
EPS -0.20
Price-to-Earnings (P/E) Ratio -11.75
Price-to-Sales 13.99
Price-to-Book 12.44
PEG Ratio -191.68
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.545
Resistance 3 (R3) 2.567 2.523 2.513
Resistance 2 (R2) 2.523 2.474 2.513 2.502
Resistance 1 (R1) 2.437 2.443 2.415 2.415 2.491
Pivot Point 2.393 2.393 2.383 2.383 2.393
Support 1 (S1) 2.307 2.344 2.285 2.285 2.209
Support 2 (S2) 2.263 2.313 2.253 2.198
Support 3 (S3) 2.177 2.263 2.188
Support 4 (S4) 2.155